Integer Holdings Corporation (ITGR)
After hours:
| Previous Close | 113.14 |
| Open | 113.73 |
| Bid | 113.87 x 800 |
| Ask | 113.94 x 900 |
| Day's Range | 112.67 - 114.29 |
| 52 Week Range | 69.40 - 123.99 |
| Volume | |
| Avg. Volume | 389,348 |
| Market Cap | 3.827B |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | 39.53 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
PLANO, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society (HRS) educational event and exhibition in Boston from May 16 – 19, 2024. HRS attendees are invited to visit Integer at booth #753 to learn more about the company’s comprehensive end-to-end solutions, designed to he
- GlobeNewswire
Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14
PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Tuesday, May 14, at 10:40 a.m. PDT. A live webcast of the presentation will be accessible under “New
- GlobeNewswire
Integer Holdings Corporation Reports First Quarter 2024 Results
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%.GAAP net income increased $7 million to $21 million, an increase of 57%. Non-GAAP adjusted net income incre
